JAK2 and acquired polycythemia vera: We therefore assessed the ex vivo effects of INCB053914 on neoplastic erythroid colony formation in primary cell cultures obtained from patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (MF) who possess the activating JAK2 V617F mutation.